Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)

Early Phase 1UnknownNCT02619721

Beijing Pins Medical Co., Ltd7 enrolled

Overview

Evaluate the long-term clinical effectiveness and safety of the PINS Sacral Neuromodulation to patients with refractory Overactive Bladder.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Refractory Overactive Bladder

Interventions

PINS SNSDEVICE

Eligibility

Sex: ALLMin age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age greater than 16 years OAB and/or OAB symptoms Refractory to standard medical therapy 100ml bladder capacity with normal upper urinary tract Good surgical candidate Able to complete study documentation and return for followup evaluation Exclusion Criteria: * Neurological conditions Stress urinary incontinence OAB symptoms caused by urinary tract infections

Locations (1)

Beijing Hospital

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

Changes in voiding frequency from baseline to the voiding frequency evaluvation period 6 month

Time frame: 6 month of stimulation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.